102 related articles for article (PubMed ID: 4298856)
1. [Treatment with secondary antitubercular agents].
Ovreberg K
Tidsskr Nor Laegeforen; 1968 May; 88(9):741-9. PubMed ID: 4298856
[No Abstract] [Full Text] [Related]
2. [Treatment of drug resistant chronic pulmonary tuberculosis with a number of tuberculostatics].
Bernard E
Bull Int Union Tuberc; 1968 Dec; 41():183-7. PubMed ID: 4303862
[No Abstract] [Full Text] [Related]
3. [Advances and principles in tuberculostatic therapy].
Bethge H
Internist (Berl); 1971 Aug; 12(8):328-31. PubMed ID: 4328130
[No Abstract] [Full Text] [Related]
4. [Actual tuberculosis therapy. An attempt to simplify and to determine a schedule of tuberculosis chemotherapy].
Virchow C
Munch Med Wochenschr; 1969 Aug; 111(35):1717-22. PubMed ID: 4309162
[No Abstract] [Full Text] [Related]
5. Treatment of patients with drug-resistance in economically developed countries.
Crofton J
Tubercle; 1969 Mar; 50():Suppl:65-8. PubMed ID: 4319134
[No Abstract] [Full Text] [Related]
6. [Cheotherapy of chronic pulmonary tuberculosis with resistant mycobacteria].
Fegiz G
Policlinico Prat; 1967 Oct; 74(43):1454-62. PubMed ID: 5629122
[No Abstract] [Full Text] [Related]
7. [Drug therapy of tuberculosis].
Jentgens H
Dtsch Med Wochenschr; 1974 Aug; 99(32):1627-30. PubMed ID: 4135677
[No Abstract] [Full Text] [Related]
8. [Experimental studies on intermittent use of rifampicin alone or combined with other secondary antituberculous drugs].
Suzuki T
Kekkaku; 1971 May; 46(5):153-64. PubMed ID: 4325363
[No Abstract] [Full Text] [Related]
9. [Chemotherapeutic studies on advanced tuberculosis in mice].
Grumbach F
Bibl Tuberc; 1965; 21():31-96. PubMed ID: 4301034
[No Abstract] [Full Text] [Related]
10. Duration of application and change of a regimen with secondary drugs.
Oka S; Takase Y; Kato S
Sci Rep Res Inst Tohoku Univ Med; 1968 Oct; 15(1):46-9. PubMed ID: 4308926
[No Abstract] [Full Text] [Related]
11. Experimental studies on therapeutic effects of various combinations of antituberculosis drugs. I. Comparison of various regimens in treatment of experimental mouse tuberculosis infected with drug-susceptible mycobacteria.
Hokama S
Jpn J Tuberc; 1967 Jul; 14(1):29-44. PubMed ID: 5300097
[No Abstract] [Full Text] [Related]
12. Ethambytol in the retreatment of pulmonary tuberculosis. United States Public Health Service cooperative trial.
Steininger WJ
Bull Int Union Tuberc; 1968 Dec; 41():181-2. PubMed ID: 4303861
[No Abstract] [Full Text] [Related]
13. Experimental studies on therapeutic effects of various combinations of antituberculosis drugs. II. Comparison of various regimens in treatment of experimental mouse tuberculosis infected with SM- and INH-resistant Schacht strain.
Hokama S
Jpn J Tuberc; 1967 Jul; 14(1):45-54. PubMed ID: 4295381
[No Abstract] [Full Text] [Related]
14. Comparative studies of various antituberculosis drug regimens by means of serum antimycobacterial activity tests in man.
Hokama S
Jpn J Tuberc; 1967 Jul; 14(1):55-65. PubMed ID: 5300098
[No Abstract] [Full Text] [Related]
15. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].
Kekkaku; 1971 Nov; 46(11):423-8. PubMed ID: 4335256
[No Abstract] [Full Text] [Related]
16. Ethambutol in the treatment of 26 patients with chronic active pulmonary tuberculosis.
Jesiotr M
Tubercle; 1969 Mar; 50():Suppl:54-5. PubMed ID: 4319133
[No Abstract] [Full Text] [Related]
17. [Comparison of combination therapy of Capreomycin, ethionamide and cycloserin with that of kanamycin, ethionamide and cycloserin for the retreatment of pulmonary tuberculosis].
Kitamoto O; Oka S; Kawamori Y; Gomi J; Sugiyama K
Saishin Igaku; 1970 Jul; 25(7):1546-55. PubMed ID: 5451178
[No Abstract] [Full Text] [Related]
18. In vitro and in vivo studies to assess the suitability of anti-tuberculous drugs for use in intermittent chemotherapy regimens.
Dickinson JM
Bull Int Union Tuberc; 1968 Dec; 41():309-15. PubMed ID: 4179554
[No Abstract] [Full Text] [Related]
19. [Th 13-14 and PZA and CS in the treatment of chronic cavitary tuberculosis with bacterial resistance to classic antibacterial drugs].
Zunić D
Tuberkuloza; 1966; 18(5):429-40. PubMed ID: 16296047
[No Abstract] [Full Text] [Related]
20. Clinical and bacteriological results with Myambutol.
Goldman S; Brzaković N; Muzikravić T
Antibiot Chemother; 1970; 16():239-56. PubMed ID: 4332036
[No Abstract] [Full Text] [Related]
[Next] [New Search]
